Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1604 entries
Sorted by: Best Match Show Resources per page
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H.
PMID: 26870193
Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10.

Tumoral cavity formation is a characteristic phenomenon reported in anti-angiogenic therapy in lung lesions. A 57-year-old male with multiple pulmonary metastases from colorectal cancer treated with an oral tyrosine kinase inhibitor, regorafenib, exhibited a characteristic cavity formation after the...

Cite
Kawasaki K, Hamamoto Y, Adachi M, et al. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2015;11(1):231-233doi: 10.3892/ol.2015.3905.
Kawasaki, K., Hamamoto, Y., Adachi, M., Kanai, T., & Takaishi, H. (2016). Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncology letters, 11(1), 231-233. https://doi.org/10.3892/ol.2015.3905
Kawasaki, Kenta, et al. "Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report." Oncology letters vol. 11,1 (2016): 231-233. doi: https://doi.org/10.3892/ol.2015.3905
Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10. PMID: 26870193; PMCID: PMC4727027.
Copy Download .nbib Format: NLM
ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis.

Cell reports

Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S.
PMID: 25683718
Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12.

Ataxia-telangiectasia (A-T) patients occasionally develop diabetes mellitus. However, only limited attempts have been made to gain insight into the molecular mechanism of diabetes mellitus development in A-T patients. We found that Atm

Cite
Takagi M, Uno H, Nishi R, et al. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015;10(6):957-967doi: 10.1016/j.celrep.2015.01.027.
Takagi, M., Uno, H., Nishi, R., Sugimoto, M., Hasegawa, S., Piao, J., Ihara, N., Kanai, S., Kakei, S., Tamura, Y., Suganami, T., Kamei, Y., Shimizu, T., Yasuda, A., Ogawa, Y., & Mizutani, S. (2015). ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell reports, 10(6), 957-967. https://doi.org/10.1016/j.celrep.2015.01.027
Takagi, Masatoshi, et al. "ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis." Cell reports vol. 10,6 (2015): 957-967. doi: https://doi.org/10.1016/j.celrep.2015.01.027
Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12. PMID: 25683718.
Copy Download .nbib Format: NLM
Contributions of natural and anthropogenic radiative forcing to mass loss of Northern Hemisphere mountain glaciers and quantifying their uncertainties.

Scientific reports

Hirabayashi Y, Nakano K, Zhang Y, Watanabe S, Tanoue M, Kanae S.
PMID: 27435236
Sci Rep. 2016 Jul 20;6:29723. doi: 10.1038/srep29723.

Observational evidence indicates that a number of glaciers have lost mass in the past. Given that glaciers are highly impacted by the surrounding climate, human-influenced global warming may be partly responsible for mass loss. However, previous research studies have...

Cite
Hirabayashi Y, Nakano K, Zhang Y, et al. Contributions of natural and anthropogenic radiative forcing to mass loss of Northern Hemisphere mountain glaciers and quantifying their uncertainties. Sci Rep. 2016;6:29723doi: 10.1038/srep29723.
Hirabayashi, Y., Nakano, K., Zhang, Y., Watanabe, S., Tanoue, M., & Kanae, S. (2016). Contributions of natural and anthropogenic radiative forcing to mass loss of Northern Hemisphere mountain glaciers and quantifying their uncertainties. Scientific reports, 629723. https://doi.org/10.1038/srep29723
Hirabayashi, Yukiko, et al. "Contributions of natural and anthropogenic radiative forcing to mass loss of Northern Hemisphere mountain glaciers and quantifying their uncertainties." Scientific reports vol. 6 (2016): 29723. doi: https://doi.org/10.1038/srep29723
Hirabayashi Y, Nakano K, Zhang Y, Watanabe S, Tanoue M, Kanae S. Contributions of natural and anthropogenic radiative forcing to mass loss of Northern Hemisphere mountain glaciers and quantifying their uncertainties. Sci Rep. 2016 Jul 20;6:29723. doi: 10.1038/srep29723. PMID: 27435236; PMCID: PMC4951733.
Copy Download .nbib Format: NLM
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

United European gastroenterology journal

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.
PMID: 27403304
United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy.METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori...

Cite
Mori H, Suzuki H, Matsuzaki J, et al. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2015;4(3):380-7doi: 10.1177/2050640615618043.
Mori, H., Suzuki, H., Matsuzaki, J., Tsugawa, H., Fukuhara, S., Miyoshi, S., Hirata, K., Seino, T., Matsushita, M., Nishizawa, T., Masaoka, T., & Kanai, T. (2016). Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European gastroenterology journal, 4(3), 380-7. https://doi.org/10.1177/2050640615618043
Mori, Hideki, et al. "Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study." United European gastroenterology journal vol. 4,3 (2016): 380-7. doi: https://doi.org/10.1177/2050640615618043
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13. PMID: 27403304; PMCID: PMC4924440.
Copy Download .nbib Format: NLM
Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.

Oncology letters

Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T.
PMID: 28599481
Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21.

Patients with pancreatic ductal adenocarcinoma (PDA) typically succumb to mortality early, even following surgical resection. Therefore, prognostic factors associated with early mortality are required to improve the survival of patients with PDA following surgical resection. Carbohydrate sulfotransferase 15 (CHST15)...

Cite
Ito Z, Takakura K, Suka M, et al. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017;13(6):4799-4805doi: 10.3892/ol.2017.6071.
Ito, Z., Takakura, K., Suka, M., Kanai, T., Saito, R., Fujioka, S., Kajihara, M., Yanagisawa, H., Misawa, T., Akiba, T., Koido, S., & Ohkusa, T. (2017). Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncology letters, 13(6), 4799-4805. https://doi.org/10.3892/ol.2017.6071
Ito, Zensho, et al. "Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma." Oncology letters vol. 13,6 (2017): 4799-4805. doi: https://doi.org/10.3892/ol.2017.6071
Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21. PMID: 28599481; PMCID: PMC5453115.
Copy Download .nbib Format: NLM
Non-Syndromic Familial Keratocystic Odontogenic Tumour: A Rare Case Report in Japanese Identical Twins.

Journal of clinical and diagnostic research : JCDR

Shimada Y, Maruoka Y, Yamaji I, Kawai S.
PMID: 27656582
J Clin Diagn Res. 2016 Aug;10(8):ZD28-30. doi: 10.7860/JCDR/2016/19411.8289. Epub 2016 Aug 01.

Keratocystic Odontogenic Tumour (KCOT) is unicystic or multicystic intraosseous benign tumour of odontogenic origin that recurs due to locally destructive behaviour. KCOTs are usually the first manifestation of Nevoid Basal Cell Carcinoma Syndrome (NBCCS), an autosomal dominant disorder also...

Cite
Shimada Y, Maruoka Y, Yamaji I, et al. Non-Syndromic Familial Keratocystic Odontogenic Tumour: A Rare Case Report in Japanese Identical Twins. J Clin Diagn Res. 2016;10(8):ZD28-30doi: 10.7860/JCDR/2016/19411.8289.
Shimada, Y., Maruoka, Y., Yamaji, I., & Kawai, S. (2016). Non-Syndromic Familial Keratocystic Odontogenic Tumour: A Rare Case Report in Japanese Identical Twins. Journal of clinical and diagnostic research : JCDR, 10(8), ZD28-30. https://doi.org/10.7860/JCDR/2016/19411.8289
Shimada, Yasuyuki, et al. "Non-Syndromic Familial Keratocystic Odontogenic Tumour: A Rare Case Report in Japanese Identical Twins." Journal of clinical and diagnostic research : JCDR vol. 10,8 (2016): ZD28-30. doi: https://doi.org/10.7860/JCDR/2016/19411.8289
Shimada Y, Maruoka Y, Yamaji I, Kawai S. Non-Syndromic Familial Keratocystic Odontogenic Tumour: A Rare Case Report in Japanese Identical Twins. J Clin Diagn Res. 2016 Aug;10(8):ZD28-30. doi: 10.7860/JCDR/2016/19411.8289. Epub 2016 Aug 01. PMID: 27656582; PMCID: PMC5028512.
Copy Download .nbib Format: NLM
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review.

OncoTargets and therapy

Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F.
PMID: 27051299
Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016.

Lipid-rich carcinoma (LRC) of the breast is a rare breast cancer variant that accounts for

Cite
Oba T, Ono M, Iesato A, et al. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016;9:1641-6doi: 10.2147/OTT.S88726.
Oba, T., Ono, M., Iesato, A., Hanamura, T., Watanabe, T., Ito, T., Kanai, T., Maeno, K., Ito, K., Tateishi, A., Yoshizawa, A., & Takayama, F. (2016). Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. OncoTargets and therapy, 91641-6. https://doi.org/10.2147/OTT.S88726
Oba, Takaaki, et al. "Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review." OncoTargets and therapy vol. 9 (2016): 1641-6. doi: https://doi.org/10.2147/OTT.S88726
Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016. PMID: 27051299; PMCID: PMC4807953.
Copy Download .nbib Format: NLM
True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires.

Nano letters

Anzai H, Suzuki M, Nagashima K, Kanai M, Zhu Z, He Y, Boudot M, Zhang G, Takahashi T, Kanemoto K, Seki T, Shibata N, Yanagida T.
PMID: 28671477
Nano Lett. 2017 Aug 09;17(8):4698-4705. doi: 10.1021/acs.nanolett.7b01362. Epub 2017 Jul 07.

Single crystalline nanowires composed of semiconducting metal oxides formed via a vapor-liquid-solid (VLS) process exhibit an electrical conductivity even without an intentional carrier doping, although these stoichiometric metal oxides are ideally insulators. Suppressing this unintentional doping effect has been...

Cite
Anzai H, Suzuki M, Nagashima K, et al. True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano Lett. 2017;17(8):4698-4705doi: 10.1021/acs.nanolett.7b01362.
Anzai, H., Suzuki, M., Nagashima, K., Kanai, M., Zhu, Z., He, Y., Boudot, M., Zhang, G., Takahashi, T., Kanemoto, K., Seki, T., Shibata, N., & Yanagida, T. (2017). True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano letters, 17(8), 4698-4705. https://doi.org/10.1021/acs.nanolett.7b01362
Anzai, Hiroshi, et al. "True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires." Nano letters vol. 17,8 (2017): 4698-4705. doi: https://doi.org/10.1021/acs.nanolett.7b01362
Anzai H, Suzuki M, Nagashima K, Kanai M, Zhu Z, He Y, Boudot M, Zhang G, Takahashi T, Kanemoto K, Seki T, Shibata N, Yanagida T. True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano Lett. 2017 Aug 09;17(8):4698-4705. doi: 10.1021/acs.nanolett.7b01362. Epub 2017 Jul 07. PMID: 28671477.
Copy Download .nbib Format: NLM
Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital.

The Canadian journal of hospital pharmacy

Nguyen ML, Toye B, Kanji S, Zvonar R, Baccaglini-Frank A, Mariotti MA.
PMID: 25964685
Can J Hosp Pharm. 2015 Mar-Apr;68(2):136-43. doi: 10.4212/cjhp.v68i2.1439.

BACKGROUND: Antimicrobial resistance due to production of extended-spectrum ß-lactamases by Escherichia coli and Klebsiella species (ESBL-EK) is concerning. Previous studies have shown that bacteremia due to ESBL-producing organisms is associated with increases in length of stay and/or mortality rate....

Cite
Nguyen ML, Toye B, Kanji S, et al. Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital. Can J Hosp Pharm. 2015;68(2):136-43doi: 10.4212/cjhp.v68i2.1439.
Nguyen, M. L., Toye, B., Kanji, S., Zvonar, R., Baccaglini-Frank, A., & Mariotti, M. A. (2015). Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital. The Canadian journal of hospital pharmacy, 68(2), 136-43. https://doi.org/10.4212/cjhp.v68i2.1439
Nguyen, My-Linh, et al. "Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital." The Canadian journal of hospital pharmacy vol. 68,2 (2015): 136-43. doi: https://doi.org/10.4212/cjhp.v68i2.1439
Nguyen ML, Toye B, Kanji S, Zvonar R, Baccaglini-Frank A, Mariotti MA. Risk Factors for and Outcomes of Bacteremia Caused by Extended-Spectrum ß-Lactamase-Producing Escherichia coli and Klebsiella Species at a Canadian Tertiary Care Hospital. Can J Hosp Pharm. 2015 Mar-Apr;68(2):136-43. doi: 10.4212/cjhp.v68i2.1439. PMID: 25964685; PMCID: PMC4414075.
Copy Download .nbib Format: NLM
Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production.

Frontiers in microbiology

Kanai T, Simons JR, Tsukamoto R, Nakajima A, Omori Y, Matsuoka R, Beppu H, Imanaka T, Atomi H.
PMID: 26379632
Front Microbiol. 2015 Aug 26;6:847. doi: 10.3389/fmicb.2015.00847. eCollection 2015.

The hyperthermophilic archaeon Thermococcus kodakarensis can utilize sugars or pyruvate for growth. In the absence of elemental sulfur, the electrons via oxidation of these substrates are accepted by protons, generating molecular hydrogen (H2). The hydrogenase responsible for this reaction...

Cite
Kanai T, Simons JR, Tsukamoto R, et al. Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production. Front Microbiol. 2015;6:847doi: 10.3389/fmicb.2015.00847.
Kanai, T., Simons, J. R., Tsukamoto, R., Nakajima, A., Omori, Y., Matsuoka, R., Beppu, H., Imanaka, T., & Atomi, H. (2015). Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production. Frontiers in microbiology, 6847. https://doi.org/10.3389/fmicb.2015.00847
Kanai, Tamotsu, et al. "Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production." Frontiers in microbiology vol. 6 (2015): 847. doi: https://doi.org/10.3389/fmicb.2015.00847
Kanai T, Simons JR, Tsukamoto R, Nakajima A, Omori Y, Matsuoka R, Beppu H, Imanaka T, Atomi H. Overproduction of the membrane-bound [NiFe]-hydrogenase in Thermococcus kodakarensis and its effect on hydrogen production. Front Microbiol. 2015 Aug 26;6:847. doi: 10.3389/fmicb.2015.00847. eCollection 2015. PMID: 26379632; PMCID: PMC4549637.
Copy Download .nbib Format: NLM
Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial.

Endoscopy international open

Hosoe N, Watanabe K, Miyazaki T, Shimatani M, Wakamatsu T, Okazaki K, Esaki M, Matsumoto T, Abe T, Kanai T, Ohtsuka K, Watanabe M, Ikeda K, Tajiri H, Ohmiya N, Nakamura M, Goto H, Tsujikawa T, Ogata H.
PMID: 27540577
Endosc Int Open. 2016 Aug;4(8):E878-82. doi: 10.1055/s-0042-111389. Epub 2016 Aug 08.

BACKGROUND AND STUDY AIMS: Olympus recently developed a new algorithm called Omni mode that discards redundant video capsule endoscopy (VCE) images. The current study aimed to demonstrate the non-inferiority of the Omni mode in terms of true positives (TPs)...

Cite
Hosoe N, Watanabe K, Miyazaki T, et al. Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial. Endosc Int Open. 2016;4(8):E878-82doi: 10.1055/s-0042-111389.
Hosoe, N., Watanabe, K., Miyazaki, T., Shimatani, M., Wakamatsu, T., Okazaki, K., Esaki, M., Matsumoto, T., Abe, T., Kanai, T., Ohtsuka, K., Watanabe, M., Ikeda, K., Tajiri, H., Ohmiya, N., Nakamura, M., Goto, H., Tsujikawa, T., & Ogata, H. (2016). Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial. Endoscopy international open, 4(8), E878-82. https://doi.org/10.1055/s-0042-111389
Hosoe, Naoki, et al. "Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial." Endoscopy international open vol. 4,8 (2016): E878-82. doi: https://doi.org/10.1055/s-0042-111389
Hosoe N, Watanabe K, Miyazaki T, Shimatani M, Wakamatsu T, Okazaki K, Esaki M, Matsumoto T, Abe T, Kanai T, Ohtsuka K, Watanabe M, Ikeda K, Tajiri H, Ohmiya N, Nakamura M, Goto H, Tsujikawa T, Ogata H. Evaluation of performance of the Omni mode for detecting video capsule endoscopy images: A multicenter randomized controlled trial. Endosc Int Open. 2016 Aug;4(8):E878-82. doi: 10.1055/s-0042-111389. Epub 2016 Aug 08. PMID: 27540577; PMCID: PMC4988834.
Copy Download .nbib Format: NLM
Simple and Easy Technique for the Placement of Seprafilm During Laparoscopic Surgery.

The Indian journal of surgery

Sumi Y, Yamashita K, Kanemitsu K, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y.
PMID: 27011601
Indian J Surg. 2015 Dec;77:1462-5. doi: 10.1007/s12262-015-1220-0. Epub 2015 Jan 18.

Laparoscopic surgery is a minimally invasive surgery, and the incidence of postoperative small bowel obstruction (SBO) is not high. However, SBO is a disease that detracts from the benefits of laparoscopic surgery due to the need for additional therapies...

Cite
Sumi Y, Yamashita K, Kanemitsu K, et al. Simple and Easy Technique for the Placement of Seprafilm During Laparoscopic Surgery. Indian J Surg. 2015;77:1462-5doi: 10.1007/s12262-015-1220-0.
Sumi, Y., Yamashita, K., Kanemitsu, K., Yamamoto, M., Kanaji, S., Imanishi, T., Nakamura, T., Suzuki, S., Tanaka, K., & Kakeji, Y. (2015). Simple and Easy Technique for the Placement of Seprafilm During Laparoscopic Surgery. The Indian journal of surgery, 771462-5. https://doi.org/10.1007/s12262-015-1220-0
Sumi, Yasuo, et al. "Simple and Easy Technique for the Placement of Seprafilm During Laparoscopic Surgery." The Indian journal of surgery vol. 77 (2015): 1462-5. doi: https://doi.org/10.1007/s12262-015-1220-0
Sumi Y, Yamashita K, Kanemitsu K, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y. Simple and Easy Technique for the Placement of Seprafilm During Laparoscopic Surgery. Indian J Surg. 2015 Dec;77:1462-5. doi: 10.1007/s12262-015-1220-0. Epub 2015 Jan 18. PMID: 27011601; PMCID: PMC4775585.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1604 entries